Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update indicating recruitment is ongoing to assess the safety and tolerability of SR-878 in adults with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SR-878

Snippet

Sponsor: SciRhom GmbH | Conditions: Rheumatoid Arthritis | Phase 1 | Status: RECRUITING